SLU-PP-332
SLU-PP-332
Research Use Only and not for human consumption. Bionk Peptides delivers high-performance research compounds engineered with uncompromising attention to detail. Every vial is produced to exceed 99% purity and supplied in lyophilised powder form, preserving molecular integrity while ensuring optimal stability and precision in application. Bionk Peptides are commitment to elevated research performance.
Couldn't load pickup availability
Description
SLU-PP-332
SLU-PP-332 is an experimental "exercise mimetic" compound that activates Estrogen-Related Receptors (ERRs) to mimic physical training benefits without increased activity. Preclinical studies indicate it boosts metabolism, significantly reduces fat mass, improves endurance, increases energy expenditure, and enhances fatty acid oxidation, promising potential for treating obesity and metabolic syndrome.
- Increased Endurance
The compound induces a change in muscle fiber composition, making them more fatigue-resistant. - Improved Insulin Sensitivity.
It has been shown to improve glucose homeostasis, aiding in blood sugar control. - Targeted Obesity & Metabolic Syndrome
It holds potential for treating metabolic syndrome, a cluster of conditions including high blood pressure and high blood sugar. - Potential for High-Risk Groups
It may eventually benefit individuals unable to exercise due to illness, injury, or frailty. - Potential COVID-19 Defence
Some research suggests it may lower the number of entry points for SARS-CoV-2 in fat tissue.
